title: Zometa in the treatment of diseminated prostate cancer.
abstract: Zoledronic acid is the first bisphosphonat that confirms the a efficacy in the treatment of bone metastases in prostate carcinoma. That is the most potent bisphosphonat up to date which safe and simple administration. Zometa is strong inhibitor of osteoclast activity.
authors: Institute of Urology and Nephrology, Clinical Center of Serbia, Belgrade.
authors: M
authors: M
authors: Djokic